Clinical trials
Phase 3 Graft vs Host Disease trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2017 | 4 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 2 |
| Mesoblast, Inc. | 2 |
| Equillium | 1 |
| Incyte Corporation | 1 |
| Kiadis Pharma | 1 |
| Martin, Paul | 1 |
| Novartis Pharmaceuticals | 1 |
| Pharmacyclics LLC. | 1 |
| The Canadian Blood and Marrow Transplant Group | 1 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graft vs Host Disease | 12 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Burkitt Lymphoma | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Leukemia, Myeloid, Accelerated Phase | 2 |
| Leukemia, Myeloid, Chronic-Phase | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Lymphoma, Follicular | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.